Damien McDevitt, Chief Executive Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 17,418 shares at $18.12 ($316K) on 2020-09-22, disclosed to the SEC on 2020-09-24.
Open-market sale of $316k AKCA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.12 | 8,709 | $158K | 50.0% |
| 2 | $18.12 | 8,709 | $158K | 50.0% |
| Total | $18.12 avg | 17,418 | $316K | 100% |